Researcher biography

Professor David Johnson PSM

Department of Nephrology, Division of Medicine, ARTS Building, Princess Alexandra Hospital

David Johnson is full-time Director of the Metro South Integrated Nephrology and Transplant Service (MINTS) and Medical Director of the Queensland Kidney Transplant Service (QKTS) at Princess Alexandra Hospital, Brisbane, Australia, Professor of Medicine and Professor of Population Health at University of Queensland, and Director of the Centre for Kidney Disease Research, Brisbane, Australia. He has a number of international leadership responsibilities, including Immediate Past President of the International Society for Peritoneal Dialysis (ISPD), President of the Australian and New Zealand Society of Nephrology (ANZSN), Past Councillor of the International Society of Nephrology (ISN) 2013-2019, Co-Chair of the ISN Global Kidney Health Atlas (ISN GKHA), Co-Chair of the Global PDOPPS Steering Committee, Chair of SONG-PD and member of the ISN-ACT, ISN Research and ISN Monitor groups. He is currently a chair or member of 11 national and 6 international guideline groups and has influenced policy and practice through his leadership as Deputy Chair of the Australian NHMRC Better Evidence And Translation in Chronic Kidney Disease (BEAT-CKD) program, Deputy Chair of the Australasian Kidney Trials Network (AKTN), Chair of the Primary Healthcare Education Advisory Committee to Kidney Health Australia (PEAK), Co-Chair of the Australasian Creatinine and eGFR Consensus Working Party, Co-Chair of the Australasian Proteinuria Consensus Working Party, Member and Past-Chair of the ANZDATA Registry Peritoneal Dialysis Working Group, and Past-Chair of the Queensland Statewide Renal Clinical Network. Having published over 1000 original manuscripts in peer-reviewed journals and presented over 550 abstracts at national and international scientific meetings, he brings critical expertise in designing and conducting multi-centre, multi-national randomised controlled trials (RCTs), developing national and international registries, and using innovative research methodologies (such as registry-based RCTs). In recent times, he has held lead roles in over 40 clinical studies, including high-impact, large, multi-centre RCTs that have informed global clinical practice, including CKD-FIX, IDEAL, balANZ, HONEYPOT, TESTING, HERO, and IMPENDIA, and is currently principal investigator of the TEACH-PD trial and chair of the PHOSPHATE Global Trial Steering Committee. He has won numerous awards for both his basic science and clinical research science studies, including the Australian and New Zealand Society of Nephrology TJ Neale Award for "outstanding contributions to nephrologic science" (2005), the US National Kidney Foundation International Distinguished Medal (2014), the Canadian Society of Nephrology Dimitrios Oreopoulos Award (2017) and the Asia-Pacific Society of Nephrology Priscilla Kincaid-Smith Medal (2021). He was a Queensland finalist in the Australian of the Year Awards in 2009 and was awarded a Public Service Medal by the Governor-General of Australia in 2011 for outstanding public service, particularly research into the early detection and management of kidney disease.